Phil Gold, McGill University

Research

Read how they describe their research on their McGill University profile.

Carcinoembryonic antigen (CEA)

Latest papers

Genetic predisposition to depression and inflammation impacts symptom burden and survival in patients with head and neck cancer: A longitudinal study.
Journal of affective disorders · 2023
Immunomodulation for unexplained recurrent implantation failure: where are we now?
Reproduction · 2022
A New Era: Immunotherapy Applied to Contemporary Cardiovascular Practice.
The Canadian journal of cardiology · 2022

All 4 publications

Latest funding

CIHR Drug Development Training Program (DDTP)
CIHR · 2008 · Co-investigator
$1,790,000

All 1 grants and awards

4 publications.

01

Genetic predisposition to depression and inflammation impacts symptom burden and survival in patients with head and neck cancer: A longitudinal study.

Henry M, Harvey R, Chen LM, Meaney M, Nguyen TTT, Kao HT, Rosberger Z, Frenkiel S, Hier M, Zeitouni A, Kost K, Mlynarek A, Richardson K, Greenwood CMT, Melnychuk D, Gold P, Chartier G, Black M, Mascarella M, MacDonald C, Sadeghi N, Sultanem K, Shenouda G, Cury F, O'Donnell KJ

Journal of affective disorders20237 citationsOpen Access

DOI: 10.1016/j.jad.2023.03.007 PMID: 36948466

02

Immunomodulation for unexplained recurrent implantation failure: where are we now?

Geneviève Genest, Shorooq Banjar, Walaa Almasri, Coralie Beauchamp, Joanne Benoit, William M Buckett, Frederick Dzineku, Phil Gold, Michael Haim Dahan, Wael Jamal, Isaac Jacques Kadoch, Einav Kadour‐Peero, Louise Lapensée, Pierre Miron, Talya Shaulov, Camille V Sylvestre, Togas Tulandi, Bruce David Mazer, Carl A. Laskin, NEAL G. MAHUTTE

Reproduction202245 citationsOpen Access

DOI: 10.1530/rep-22-0150 PMID: 36322478

03

A New Era: Immunotherapy Applied to Contemporary Cardiovascular Practice.

Filimon S, Pop C, Chetrit M, Esfahani K, Hudson M, Rouleau J, Thanassoulis G, O'Meara E, Bouabdallaoui N, Michel C, Aziz H, Gold P, Tardif JC, Huynh T

The Canadian journal of cardiology2022

DOI: 10.1016/j.cjca.2022.05.013 PMID: 35598801

04

Physical health status of music students in a post-secondary institution: A cross-sectional study.

Ying-Lun Chang A, Boone H, Gold P

Work (Reading, Mass.)2021Senior author

DOI: 10.3233/wor-213621 PMID: 34842221

CIHR Drug Development Training Program (DDTP)

Co-investigatorCIHR2008Training Grant

Principal investigators: Papadopoulos, Vassilios; Bergeron, John J; Damha, Masad J; Hales, Barbara F; Hébert, Terence E; Jean-Claude, Bertrand J; Laporte, Stéphane A; Moitessier, Nicolas R; Robaire, Bernard; Ward, Brian J

Keywords: Academia; Clinical Trials; Drug Discovery; Experimental Therapeutics; Industry

$1,790,000

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Department of Medicine
Department of Psychiatry
Gerald Bronfman Department of Oncology
Epidemiology, Biostatistics and Occupational Health
Department of Mathematics
Medicine/Cardiology
Oncology
Other

Applying for

Paper to mention

Subject: Prospective PhD student: Carcinoembryonic antigen (CEA) Dear Professor Gold, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Genetic predisposition to depression and inflammation impacts symptom burden and survival in patients with head and neck cancer: A longitudinal study." (2023), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]